Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Semela

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Clinical Reviews in Allergy & Immunology|November 29, 2017
Geoepidemiology of Primary Biliary Cholangitis: Lessons from SwitzerlandBenedetta Terziroli Beretta-Piccoli, Guido Stirnimann, Andreas Cerny, et al.
Journal of Hepatology|April 17, 2017
Visualization of hepatitis E virus RNA and proteins in the human liverDaniela Lenggenhager, Jérôme Gouttenoire, Mohsen Malehmir, et al.
Swiss Medical Weekly|January 30, 2018
Excellent outcome of direct antiviral treatment for chronic hepatitis C in SwitzerlandJacqueline Bachofner, Piero V Valli, Irina Bergamin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2017
A systematic review and meta-analysis of HCV clearanceEmeline Gauthiez, Ines Habfast-Robertson, Sina Rüeger, et al.
Frontiers in Genetics|November 22, 2019
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation SequencingFrédégonde About, Stéphanie Bibert, Emmanuelle Jouanguy, et al.
Life Science Alliance|December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosisRobert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
Nature Communications|June 30, 2015
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Clinical Reviews in Allergy & Immunology|November 29, 2017
Geoepidemiology of Primary Biliary Cholangitis: Lessons from SwitzerlandBenedetta Terziroli Beretta-Piccoli, Guido Stirnimann, Andreas Cerny, et al.
Journal of Hepatology|April 17, 2017
Visualization of hepatitis E virus RNA and proteins in the human liverDaniela Lenggenhager, Jérôme Gouttenoire, Mohsen Malehmir, et al.
Swiss Medical Weekly|January 30, 2018
Excellent outcome of direct antiviral treatment for chronic hepatitis C in SwitzerlandJacqueline Bachofner, Piero V Valli, Irina Bergamin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2017
A systematic review and meta-analysis of HCV clearanceEmeline Gauthiez, Ines Habfast-Robertson, Sina Rüeger, et al.
Frontiers in Genetics|November 22, 2019
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation SequencingFrédégonde About, Stéphanie Bibert, Emmanuelle Jouanguy, et al.
Life Science Alliance|December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosisRobert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
Nature Communications|June 30, 2015
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Pageof 10